BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20697133)

  • 1. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.
    Abulkhair O; Saghir N; Sedky L; Saadedin A; Elzahwary H; Siddiqui N; Al Saleh M; Geara F; Birido N; Al-Eissa N; Al Sukhun S; Abdulkareem H; Ayoub MM; Deirawan F; Fayaz S; Kandil A; Khatib S; El-Mistiri M; Salem D; Sayd el SH; Jaloudi M; Jahanzeb M; Gradishar WI;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S8-S15. PubMed ID: 20697133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.
    Hassen WA; Karsan FA; Abbas F; Beduk Y; El-Khodary A; Ghosn M; Khader J; Khauli R; Rabah DM; Shamseddine A; Srinivas S;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S26-8. PubMed ID: 20697128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region.
    Jazieh AR; Bamefleh H; Demirkazik A; Gaafar RM; Geara FB; Javaid M; Khader J; Khodadad K; Omar W; Saadeddin A; Sabe HA; Shadmehr MB; El Sherif A; Uddin N; Jahanzeb M; Ettinger D;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S16-21. PubMed ID: 20697125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.
    Içli F; Akbulut H; Bazarbashi S; Kuzu MA; Mallath MK; Rasul KI; Strong S; Syed AA; Zorlu F; Engstrom PF;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S22-5. PubMed ID: 20697127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region.
    Shamieh O; Jazieh AR;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S41-7. PubMed ID: 20697131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
    Bazarbachi A; Azim HA; Alizadeh H; Aljurf M; Barista I; Chaudhri NA; Fahed Z; Fahmy OA; Ghavamzadeh A; Khalaf MH; Khatib S; Kutoubi A; Paydas S; Elayoubi HR; Zaatari G; Zawam HM; Zelenetz AD;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S29-35. PubMed ID: 20697129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.
    Yusuf MA; Kapoor VK; Kamel RR; Kazmi A; Uddin N; Masood N; Al-Abdulkareem A;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S36-40. PubMed ID: 20697130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The process of NCCN guidelines adaptation to the Middle East and North Africa region.
    Jazieh AR; Azim HA; McClure J; Jahanzeb M
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S5-7. PubMed ID: 20697132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.
    Wasif N; Ye X; Giuliano AE
    Ann Surg Oncol; 2009 Sep; 16(9):2442-9. PubMed ID: 19506955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCCN: Breast cancer.
    Carlson RW; Edge SB; Theriault RL;
    Cancer Control; 2001; 8(6 Suppl 2):54-61. PubMed ID: 11760559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
    Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz MP; Goldstein LJ; Isakoff SJ; Lyons J; Marcom PK; Mayer IA; McCormick B; Moran MS; O'Regan RM; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Sitapati A; Smith KL; Smith ML; Soliman H; Somlo G; Telli ML; Ward JH; Kumar R; Shead DA
    J Natl Compr Canc Netw; 2018 Mar; 16(3):310-320. PubMed ID: 29523670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA region.
    Elghazaly H; Aref AT; Anderson BO; Arun B; Yip CH; Abdelaziz H; Ghosn M; Al-Foheidi M; Cardenosa G; Leung JWT; Gado N; Balch CM; Sabry M; Ezz Elarab L; Giuliano AE; El-Zawahry HM; Abdel Karim K; Nasr A; Maki H; Chung H; Saadeddin A; Abdelwahab MM; Al Tahan FM; Chalabi N; Frolova M; Kamal RM; Shehata MA; Bahie Eldin N; Elghazawy H
    Int J Cancer; 2021 Aug; 149(3):505-513. PubMed ID: 33559295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update: NCCN breast cancer clinical practice guidelines.
    Carlson RW; Edge SB
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-1-4. PubMed ID: 23570090
    [No Abstract]   [Full Text] [Related]  

  • 15. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.
    García Fernández A; Chabrera C; García Font M; Fraile M; Lain JM; Barco I; González C; Gónzalez S; Reñe A; Veloso E; Cassadó J; Pessarrodona A; Giménez N
    Breast; 2013 Oct; 22(5):902-7. PubMed ID: 23684000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Audit system on quality of breast cancer diagnosis and treatment: results of quality indicators on screen-detected lesions in Italy, 2010].
    Ponti A; Mano MP; Tomatis M; Baiocchi D; Barca A; Berti R; Bisanti L; Casella D; Deandrea S; Delrio D; Donati G; Falcini F; Frammartino B; Frigerio A; Mantellini P; Naldoni C; Orzalesi L; Pagano G; Pietribiasi F; Ravaioli A; Sedda ML; Taffurelli M; Cataliotti L; Segnan N
    Epidemiol Prev; 2012; 36(6 Suppl 1):87-95. PubMed ID: 23293273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International adaptation and use of NCCN Guidelines.
    Bazarbachi A; Zelenetz AD
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):838-41. PubMed ID: 24853230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
    Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
    [No Abstract]   [Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in breast cancer New indications and our experience.
    Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
    Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.